Send us a Message
Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Search RGD Grant Resources Citing RGD About Us Contact Us
Genes Variants Community Projects QTLs Strains Markers Genome Information Ontologies Cell Lines References Download Submit Data
OntoMate (Literature Search) JBrowse (Genome Browser) Synteny Browser (VCMap) Variant Visualizer Multi-Ontology Enrichment (MOET) Gene-Ortholog Location Finder (GOLF) InterViewer (Protein-Protein Interactions) PhenoMiner (Quatitative Phenotypes) Gene Annotator OLGA (Gene List Generator) AllianceMine GViewer (Genome Viewer)
Aging & Age-Related Disease Cancer & Neoplastic Disease Cardiovascular Disease Coronavirus Disease Developmental Disease Diabetes Hematologic Disease Immune & Inflammatory Disease Infectious Disease Liver Disease Neurological Disease Obesity & Metabolic Syndrome Renal Disease Respiratory Disease Sensory Organ Disease
Find Models   new Genetic Models Autism Models Rat PhenoMiner (Quantitative Phenotypes) Chinchilla PhenoMiner Expected Ranges (Quantitative Phenotype) PhenoMiner Term Comparison Hybrid Rat Diversity Panel Phenotypes Phenotypes in Other Animal Models Animal Husbandry Strain Medical Records Phylogenetics Strain Availability Calendar Rats 101 Submissions Photo Archive
Pathways
Rat Community Forum Directory of Rat Laboratories Video Tutorials News RGD Publications RGD Presentations Archive Nomenclature Guidelines Resource Links Laboratory Resources Employment Resources

CHEBI ONTOLOGY - ANNOTATIONS

The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term:indolizidine alkaloid
go back to main search page
Accession:CHEBI:38511 term browser browse the term
Synonyms:related_synonym: indolizidine alkaloids;   indolizine alkaloids
 xref: Patent:WO9106547


show annotations for term's descendants           Sort by:
lycorine term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Ccnd3 cyclin D3 decreases expression ISO lycorine results in decreased expression of CCND3 mRNA CTD PMID:23376478 NCBI chr 9:13,394,161...13,400,341
Ensembl chr 9:13,394,169...13,489,371 		JBrowse link
G Cdh5 cadherin 5 decreases expression ISO lycorine results in decreased expression of CDH5 mRNA CTD PMID:23376478 NCBI chr19:815,415...854,478
Ensembl chr19:815,411...854,368 		JBrowse link
G Cdkn1a cyclin-dependent kinase inhibitor 1A increases expression ISO lycorine results in increased expression of CDKN1A mRNA CTD PMID:23376478 NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585 		JBrowse link
G Il6 interleukin 6 multiple interactions ISO lycorine inhibits the reaction [Lipopolysaccharides results in increased secretion of IL6 protein] CTD PMID:22155741 NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178 		JBrowse link
G Mapk14 mitogen activated protein kinase 14 multiple interactions ISO lycorine inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK14 protein] CTD PMID:22155741 NCBI chr20:6,749,646...6,810,590
Ensembl chr20:6,749,670...6,810,589 		JBrowse link
G Nos2 nitric oxide synthase 2 multiple interactions ISO lycorine inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]; lycorine inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] CTD PMID:22155741 NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210 		JBrowse link
G Ptgs2 prostaglandin-endoperoxide synthase 2 multiple interactions ISO lycorine inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein] CTD PMID:22155741 NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188 		JBrowse link
G Sema4d semaphorin 4D decreases expression ISO lycorine results in decreased expression of SEMA4D mRNA CTD PMID:23376478 NCBI chr17:13,430,324...13,537,146
Ensembl chr17:13,430,379...13,537,138 		JBrowse link
G Stat1 signal transducer and activator of transcription 1 multiple interactions ISO lycorine inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of STAT1 protein] CTD PMID:22155741 NCBI chr 9:49,419,561...49,459,969
Ensembl chr 9:49,419,340...49,588,540 		JBrowse link
G Stat3 signal transducer and activator of transcription 3 multiple interactions ISO lycorine inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of STAT3 protein] CTD PMID:22155741 NCBI chr10:85,811,206...85,863,057
Ensembl chr10:85,811,218...85,863,057 		JBrowse link
G Tnf tumor necrosis factor multiple interactions ISO lycorine inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein] CTD PMID:22155741 NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629 		JBrowse link
G Vegfa vascular endothelial growth factor A decreases expression ISO lycorine results in decreased expression of VEGFA mRNA CTD PMID:23376478 NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641 		JBrowse link
swainsonine term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Aifm1 apoptosis inducing factor, mitochondria associated 1 increases expression EXP Swainsonine results in increased expression of AIFM1 protein CTD PMID:33186601 NCBI chr  X:127,650,223...127,689,356
Ensembl chr  X:127,650,226...127,689,256 		JBrowse link
G Akt1 AKT serine/threonine kinase 1 decreases phosphorylation ISO Swainsonine results in decreased phosphorylation of AKT1 protein CTD PMID:36402259 NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921 		JBrowse link
G Atg5 autophagy related 5 multiple interactions
increases expression		 ISO
EXP		 [bafilomycin A1 co-treated with Swainsonine] results in increased expression of ATG5 mRNA; [bafilomycin A1 co-treated with Swainsonine] results in increased lipidation of ATG5 protein
Swainsonine results in increased expression of ATG5 mRNA; Swainsonine results in increased expression of ATG5 protein		 CTD PMID:36402259 PMID:37442287 NCBI chr20:47,798,217...47,889,216
Ensembl chr20:47,798,290...47,889,209 		JBrowse link
G Becn1 beclin 1 multiple interactions
increases expression		 EXP
ISO		 [Swainsonine co-treated with bafilomycin A1] results in increased expression of BECN1 protein
Swainsonine results in increased expression of BECN1 protein
Swainsonine results in increased expression of BECN1 mRNA; Swainsonine results in increased expression of BECN1 protein		 CTD PMID:33186601 PMID:36402259 NCBI chr10:86,231,387...86,246,742
Ensembl chr10:86,231,388...86,246,742 		JBrowse link
G Casp3 caspase 3 multiple interactions
increases cleavage		 EXP [Swainsonine co-treated with aloxistatin] results in increased cleavage of CASP3 protein; [Swainsonine co-treated with bafilomycin A1] results in increased cleavage of CASP3 protein
Swainsonine results in increased cleavage of CASP3 protein		 CTD PMID:33186601 NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648 		JBrowse link
G Casp8 caspase 8 increases cleavage EXP Swainsonine results in increased cleavage of CASP8 protein CTD PMID:33186601 NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542 		JBrowse link
G Casp9 caspase 9 increases cleavage
multiple interactions		 EXP Swainsonine results in increased cleavage of CASP9 protein
[Swainsonine co-treated with Sirolimus] results in increased cleavage of CASP9 protein		 CTD PMID:33186601 NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626 		JBrowse link
G Ctsd cathepsin D decreases expression
multiple interactions		 EXP Swainsonine results in decreased expression of CTSD protein
[Swainsonine affects the glycosylation of CTSD protein] which results in decreased expression of CTSD protein modified form		 CTD PMID:33186601 PMID:37442287 NCBI chr 1:197,527,467...197,539,343
Ensembl chr 1:197,527,467...197,539,488 		JBrowse link
G Eif4ebp1 eukaryotic translation initiation factor 4E binding protein 1 decreases phosphorylation ISO Swainsonine results in decreased phosphorylation of EIF4EBP1 protein CTD PMID:36402259 NCBI chr16:64,792,595...64,805,984
Ensembl chr16:64,790,226...64,805,984 		JBrowse link
G Faslg Fas ligand increases expression EXP Swainsonine results in increased expression of FASLG protein CTD PMID:33186601 NCBI chr13:74,151,519...74,172,760
Ensembl chr13:74,154,954...74,162,215 		JBrowse link
G Gfpt1 glutamine fructose-6-phosphate transaminase 1 decreases expression EXP Swainsonine results in decreased expression of GFAT1 protein CTD PMID:37442287 NCBI chr 4:119,496,691...119,546,472
Ensembl chr 4:119,496,714...119,546,471 		JBrowse link
G Lamp1 lysosomal-associated membrane protein 1 multiple interactions
increases expression		 ISO [bafilomycin A1 co-treated with Swainsonine] results in increased expression of LAMP1 mRNA; [bafilomycin A1 co-treated with Swainsonine] results in increased expression of LAMP1 protein
Swainsonine results in increased expression of LAMP1 mRNA; Swainsonine results in increased expression of LAMP1 protein		 CTD PMID:36402259 NCBI chr16:76,355,982...76,380,700
Ensembl chr16:76,355,984...76,381,883 		JBrowse link
G Man2a1 mannosidase, alpha, class 2A, member 1 multiple interactions
decreases expression		 ISO bafilomycin A1 inhibits the reaction [Swainsonine results in decreased expression of MAN2A1 mRNA] CTD PMID:36402259 NCBI chr 9:104,252,001...104,408,349
Ensembl chr 9:104,252,001...104,408,349 		JBrowse link
G Man2b1 mannosidase, alpha, class 2B, member 1 multiple interactions
decreases expression		 ISO bafilomycin A1 inhibits the reaction [Swainsonine results in decreased expression of MAN2B1 mRNA] CTD PMID:36402259 NCBI chr19:23,055,092...23,074,398
Ensembl chr19:23,055,097...23,074,389 		JBrowse link
G Map1lc3b microtubule-associated protein 1 light chain 3 beta multiple interactions
increases expression
increases lipidation		 ISO
EXP		 [bafilomycin A1 co-treated with Swainsonine] results in increased expression of MAP1LC3B mRNA; [bafilomycin A1 co-treated with Swainsonine] results in increased lipidation of MAP1LC3B protein
Swainsonine results in increased expression of MAP1LC3B mRNA
Swainsonine results in increased lipidation of MAP1LC3B protein
Swainsonine results in increased localization of and results in increased lipidation of MAP1LC3B protein		 CTD PMID:36402259 PMID:37442287 NCBI chr19:49,665,795...49,673,655
Ensembl chr19:49,665,791...49,677,690 		JBrowse link
G Mapk1 mitogen activated protein kinase 1 decreases phosphorylation ISO Swainsonine results in decreased phosphorylation of MAPK1 protein CTD PMID:36402259 NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616 		JBrowse link
G Mapk3 mitogen activated protein kinase 3 decreases phosphorylation ISO Swainsonine results in decreased phosphorylation of MAPK3 protein CTD PMID:36402259 NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863 		JBrowse link
G Mtor mechanistic target of rapamycin kinase decreases phosphorylation ISO Swainsonine results in decreased phosphorylation of MTOR protein CTD PMID:36402259 NCBI chr 5:158,884,856...158,994,311
Ensembl chr 5:158,884,804...158,994,311 		JBrowse link
G Pik3r1 phosphoinositide-3-kinase regulatory subunit 1 decreases phosphorylation ISO Swainsonine results in decreased phosphorylation of PIK3R1 protein CTD PMID:36402259 NCBI chr 2:32,878,942...32,963,668
Ensembl chr 2:32,882,032...32,963,631 		JBrowse link
G Rps6kb1 ribosomal protein S6 kinase B1 decreases phosphorylation ISO Swainsonine results in decreased phosphorylation of RPS6KB1 protein CTD PMID:36402259 NCBI chr10:71,323,777...71,367,908
Ensembl chr10:71,323,777...71,367,908 		JBrowse link
G Sqstm1 sequestosome 1 increases expression
multiple interactions		 ISO
EXP		 Swainsonine results in increased expression of SQSTM1 mRNA; Swainsonine results in increased expression of SQSTM1 protein
[bafilomycin A1 co-treated with Swainsonine] results in increased expression of SQSTM1 mRNA; [bafilomycin A1 co-treated with Swainsonine] results in increased lipidation of SQSTM1 protein		 CTD PMID:36402259 PMID:37442287 NCBI chr10:34,525,517...34,536,670
Ensembl chr10:34,525,519...34,536,673 		JBrowse link
G Tfeb transcription factor EB decreases expression EXP Swainsonine results in decreased expression of TFEB protein CTD PMID:33186601 NCBI chr 9:13,198,890...13,254,726
Ensembl chr 9:13,198,891...13,254,714 		JBrowse link
G Tp53 tumor protein p53 increases expression ISO Swainsonine results in increased expression of TRP53 protein CTD PMID:36402259 NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524 		JBrowse link
Term paths to the root
Path 1
Term Annotations click to browse term
  CHEBI ontology 19808
    role 19784
      biological role 19782
        biochemical role 19496
          metabolite 19484
            alkaloid 7821
              indolizidine alkaloid 35
                (1R,8aS)-octahydroindolizin-1-ol(1+) 0
                (8aS)-octahydroindolizin-1-one(1+) 0
                caranine + 0
                castanospermine 0
                erythrinan 0
                galanthan + 12
                lycorine 12
                slaframine 0
                swainsonine 23
                tashiromine + 0
Path 2
Term Annotations click to browse term
  CHEBI ontology 19808
    subatomic particle 19806
      composite particle 19806
        hadron 19806
          baryon 19806
            nucleon 19806
              atomic nucleus 19806
                atom 19806
                  main group element atom 19756
                    p-block element atom 19756
                      carbon group element atom 19705
                        carbon atom 19702
                          organic molecular entity 19702
                            organic molecule 19655
                              organic cyclic compound 19468
                                organic heterocyclic compound 18848
                                  organic heteropolycyclic compound 18278
                                    organic heterobicyclic compound 17216
                                      indolizines 76
                                        indolizidine alkaloid 35
                                          (1R,8aS)-octahydroindolizin-1-ol(1+) 0
                                          (8aS)-octahydroindolizin-1-one(1+) 0
                                          caranine + 0
                                          castanospermine 0
                                          erythrinan 0
                                          galanthan + 12
                                          lycorine 12
                                          slaframine 0
                                          swainsonine 23
                                          tashiromine + 0
paths to the root